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no one helped with their daily activities, 36% (n150) said their spouse helped
them, followed by child (9%, n37), friend (7%, n29), another relative (5%, n21),
parent (3%, n12), paid helper (3%, n12), visiting doctor/nurse (3%, n12). Among
those who sought caregiver help on daily basis (n195), two-thirds (64%) reported
being cared for by spouse, 42% said a friend, and 21% their child. When asked, who
helped (always/sometimes) in making health and medical care decision, 86% said
spouse, 51 % friend, and 46% child. Almost two-thirds (63%) indicated they had
right amount of caregiver support in making treatment choice for blood transfu-
sion, 61% reported they made an informed decision, whereas, 40% said they felt
pressured by others. Higher percentage (74%) of previously transfused individuals
agreed they have right amount of caregiver support inmaking a transfusion choice
compared to not transfused group (55%). CONCLUSIONS: Caregivers play an im-
portant role in helping individuals with their health and medical treatment deci-
sions. On a daily basis, primary caregivers are spouse, child, and friend. Individuals
have right amount of caregiver support when making treatment decisions.
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OBJECTIVES: Post-transplant expectations can be overwhelming. We assessed the
relationship between health literacy and unmet immunosuppressant (IS) drug in-
formation needs in kidney transplant recipients. We hypothesized that patients
with low health literacy have greater unmet IS drug information needs compared
to patients with optimal health literacy. METHODS: A cross-sectional survey was
mailed out to 300 kidney transplant patients recruited from a single urban trans-
plant center. Inclusion criteria were receiving post-transplant care at the center
and receiving the transplant 1 to 36 months before inception of the survey. A
validated scale measured functional, communicative and critical health literacy.
An unmet IS drug information need was defined as a person reporting some to a
significant problem and too little information on areas related to IS drug manage-
ment. A personwith 7 ormore unmet IS drug information needswas categorized as
having high unmet IS drug information needs. Logistic regression was used to
produce unadjusted and adjusted OR controlling for age, race, gender, and time
since transplant. RESULTS: A response rate of 50% was obtained. 61.3% of respon-
dents weremale and themean agewas 56.7 (/ 11.2) years. Cronbach’s alphas for
functional, communicative, and critical health literacy respectively were 0.87, 0.88
and 0.83. Patients with high functional health literacy (ORunadjusted: 0.23 [0.07,
0.82]; ORadjusted: 0.26 [0.06, 1.09]) and patients using the transplant staff as a
source of information about transplant medications (ORunadjusted: 0.43 [0.19,
0.94]; ORadjusted: 0.28 [0.10, 0.78]) were less likely to report high unmet IS drug
information needs. CONCLUSIONS: Patients with low functional health literacy
have high unmet IS drug information needs, which might affect the management
of their condition. It is important to assess patients’ health literacy, tailor commu-
nication and materials accordingly, and regularly reinforce IS issues in order to
meet their IS drug information needs.
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OBJECTIVES: Examine knowledge and information seeking behaviors towards
blood transfusions among individualswithChronic KidneyDisease (CKD) currently
not on dialysis. METHODS: An online survey was conducted from a nationally
representative patient panel in 1Q2011. Respondents were 18 years and diag-
nosed with CKD by a physician. Participants were asked about blood transfusion
history, information seeking behaviors, and knowledge about blood transfusion.
RESULTS: Of 416 respondents, 59% (n246) were female; 40% (n165) were 65
years. 35% (n144) had stage 4 and 58% (n240) stage 3 CKD. 54% (n226) were
anemic. 43% (n179) had received blood transfusion, whereas, 57% (n237) had no
transfusions. Top two sources of information were doctor (93.8%) and Internet
(80.5%). Among those previously transfused, 62% received right amount of infor-
mation, whereas, 34.6% received too little information, and 3.4% reported receiving
too much information. More than 80% of transfused indicated they knew the rea-
sons for and benefits of getting a blood transfusion. Less than two-thirds received
information about effects, risks, and time it would take, and only 26% knew the
costs. Over 60% said that it is extremely important to know right blood type, screen-
ing techniques and quality of blood, and risks of infections. Among previously
transfused, only half (50%) agreed that theymade an informed choice about receiv-
ing blood transfusions. Among the previously transfused, 77% agree that they
knew the benefits compared with 49% not transfused. Similarly among previously
transfused, 69% agreed that they knew the risks of blood transfusion compared to
51% with no transfusion history. CONCLUSIONS: Doctor’s office and Internet are
primary sources of information about blood transfusions. Gaps in knowledge exist
about benefits, risks, and costs of blood transfusions. A significant number feel that
they need more information about blood transfusion to make an informed choice.
Providers should consider adopting shared-decision making with their patients.
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OBJECTIVES: To evaluate the reliability and validity of the Thai translation of the
KDQOL-36 questionnaire, by focus on kidney disease specific dimensions. The
KDQOL-36 consists of SF-12, and 3 dimensions of kidney disease questionnaires
(the Symptom/ Problem list, Effects of Kidney Disease on Daily Life, and Burden of
Kidney disease).METHODS: Subjects were 167 hemodialysis patients and 62 peri-
toneal dialysis patients. Reliability was evaluated by using intraclass correlation
coefficients (ICCs) for test-retest reliability assessment with face to face inter-
view and Cronbach’s alpha for internal consistency. Construct validity was sup-
ported with convergent and discriminant validity using correlation between
SF-36, EQ-5D, VAS parameter and 3 dimensions of kidney disease question-
naires. Statistical analysis included descriptive statistics, Mann-Whitney U test,
and Cronbach’s alpha. RESULTS: Construct validity was satisfactory with the sig-
nificant difference less than 0.001 between two groups (lowest through 25 percen-
tile and higher than 75 percentile). The reliability coefficient for the Cronbach’s
alpha of the total scale of the KDQOL-36 were greater than 0.700 for all domains,
range from 0.706 to 0.827. ICCs ranging from 0.713 to 0.999. CONCLUSIONS: The
KDQOL-36 (Thai) is an appropriate tool for quality of life assessment and routine
care in dialysis patients.
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OBJECTIVES: Initial mass dose, renal disease recurrence, and immunosuppressant
nephrotoxicity affect long term graft function after kidney transplantation (KTx).
Chronic Kidney Disease (CKD) may impair work ability, job performance and in-
crease absenteeism. We sougt to evaluate the association of post-transplant CKD
with work ability and labor supply.METHODS:We contacted all patients at 2 Mid-
western KTx clinics. All consenting patients answered a questionnaire about socio-
demographic characters, working conditions, quality of life and work ability (Work
Ability Index, WAI). A second survey about labor supply was sent after 6 months.
We abstracted biochemistry results, treatments and comorbidities data from clin-
ical charts. We excluded patients with multiple or multi-organ transplant, and
laboratory evidence of an acute cardiac ischemic episode in the month prior to
assessment. At least one creatinine assessment in the 3 months screening period
and age between 18-65 yearswas required for inclusion.We assessed differences in
WAI and labor supply across CKD stages and Glomerular Filtration Rate (GFR) with
ordinary least square regression. RESULTS: We enrolled 577 patients in 2 mid-
westen clinic (response rate 82%). Of them 222met the inclusion/exclusion criteria.
The employment-to-population ratio was 63%. MeanWAI score was 38.85.9. CKD
severity was associated with WAI ( -0.24, p0.01). GFR was associated with WAI
after adjusting for possible confounders (0.06; p0.01). Ninty-three percent of
patients responded to the follow up survey. Of those employed at baseline 20% lost
their job and 25% of previously jobless had found one. Patients with severe CKD
worked 4.69 weeks less than subject with mild or moderate CKD (p0.03). GFR was
associated with labor supply during the 6-months follow up after adjusting for
possible confounders (0.07; p0.03) CONCLUSIONS: Severe CKD was associated
with a mild reduction in self-reported work ability and a strong reduction in labor
supply after kidney transplant.
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OBJECTIVES: Hemodialysis (HD) patients are frequently hospitalized. Interruption
of normal dialysis and 3x/weekly ESA treatments, along with the cause of hospi-
talization, usually leads to declines in Hb and increased ESA utilization post-hos-
pitalization. To determine the impact of these changes on patient care and re-
source utilization, we assessed the time for HD patients to recover to pre-
hospitalization ESA dose levels. METHODS: In this retrospective time-to-event
analysis, we examined hospitalizations in adult (318 yrs old) HD patients from
January 1, 2009 to December 31, 2010. Hospitalizations preceded by  30 hospital-
free days were included. For patients experiencing increases in epoetin alfa (EPO)
dose in the 30 days after hospitalization versus the 30 days before, we determined
the number of days taken to achieve an EPO dose  the median per-session dose
before hospitalization. Patient timewas censored at re-hospitalization, transplant,
death, or discontinuation of dialysis. Pre-hospitalization EPO dose level was con-
sidered achieved at the first of 3 consecutive dialysis sessionswhere EPOwas given
at a dose  the median per-session dose in the 30 days pre-hospitalization.
RESULTS: A total of 88,627 hospitalization events were analyzed where EPO use
increased post-hospitalization; in 40% of these cases patients were censored
(mainly due to re-hospitalization) before reaching pre-hospitalization dose. Of
those where EPO dose recovered to pre-hospitalization levels, median time to
recovery was 49 days (mean 102 days). Restricting the analysis to patients with
pre-hospitalizationmedian doses not in the top or bottom 10% of the range gave
a median time to recovery of 51 days (mean 90 days). CONCLUSIONS: Hospital-
izations frequently require an increase in post-hospitalization EPO dose. In
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